Han Ryu

Qorvo Biotechnologies is a business unit of Qorvo, Inc. Leveraging Qorvo’s expertise in Radio Frequency and miniaturized wafer technology, Qorvo Biotechnologies is developing an innovative POC diagnostic platform that combines multi-GHz bulk acoustic wave detection arrays with microfluidics and electronics integration.

Accelerate Diagnostics, Inc. is a publicly traded in vitro diagnostics company dedicated to providing innovative solutions for the global challenge of antibiotic resistance and hospital acquired infections. Responsible for • Short and long term strategic planning process • Product life cycle management • Product portfolio strategy • Innovation go-to-market strategies • Brand and marketing communication

MedTest is a PE backed clinical diagnostics company that markets chemistry, diabete and toxicology products worldwide under the brand names of Pointe Scientific, Medical Laboratory Solutions, Clinitox Diagnositics, and MedTest DX. Responsible for leading the strategic growth of in-vitro diagnostics company that delivers automated, fast, and cost effective testing solutions for diabetes, cardiovascular disease, pain management, wellness, and more. Drove the strategic growth and expansion of the business through organic and non-organic activities including strategic alliances and acquisitions. Identified and completed three add-on acquisitions that transformed a US based, single product line distribution company into a global, multiple product line, and proprietary content business portfolio Built a cohesive functional leadership team managing 80 employees while fostering customer centric, collaborative, result-oriented organizational culture. Drove continuous improvements in supply chain and operational functions.

As a member of the Siemens Healthcare Diagnostic Executive leadership team Led a corporate level strategic planning process orchestrating regional and business operating units and provided a thought partnership to CEO Completed 20+ year long term technology and innovation strategy project that delivered clear pathways to the selected opportunities Established “Strategic Innovation Group” resulting in the early investments in new emerging segments

Provided overall leadership, strategy, and direction for $700MM business units with P&L responsibility Created a long term business vision and strategy that redefines core business, business portfolio strategy, investment allocation, and new product development strategy Restructured new product development portfolio resulting in greater focus on core projects and tighter alignment with new growth strategy, which resulted in above market growth Turned internally focused R&D into a high performing customer centered product life cycle management organization through launching “customer connection program”

• Expertise in strategy and marketing but well rounded with operational and sales experience • Organizational transformation changing fundamentally the way of operating marketing and product life cycle management • Orchestrate value based pricing initiative "Prove It" • Led global CRM and customer segmentation initiatives

• Led case teams of 10-30 people including client team • Industry experience includes consumer electronics, telecommunication, banking, real estate, healthcare • Functional experience includes strategy development, mergers & acqusitions, business portfolio management, growth strategy, reengineering, sales and marketing